The treatment of cervical dystonia with botulinum toxins

Journal of Neural Transmission

Volumn 115, Issue 4, 2008, Pages 579-583

  Comella, C L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Botulinum toxins; Cervical dystonia; Controlled trials; Review; Spasmodic torticollis

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; NT 201; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

BIOEQUIVALENCE; BODY POSTURE; CLINICAL TRIAL; DISABILITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; DYSTONIA; HEADACHE; HUMAN; IMMUNITY; NECK WEAKNESS; PAIN; PRIORITY JOURNAL; REVIEW; SEROTYPE; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VOICE CHANGE; XEROSTOMIA;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; HUMANS; TORTICOLLIS;

EID: 42149163523     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0831-4     Document Type: Review

References (30)

1. R Benecke WH Jost P Kanovsky E Ruzicka G Comes S Grafe 2005 A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia Neurology 64 1949 1951
2. B Berman L Seeberger R Kumar 2004 Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia Mov Disord 20 233 237
3. JW Brans R Lindeboom JW Snoek MJ Zwarts TW van Weerden ER Brunt JJ van Hilten W van der Kamp MH Prins JD Speelman 1996 Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial Neurology 46 1066 1072
4. A Brashear MF Lew DD Dykstra CL Comella SA Factor RL Rodnitzky R Trosch C Singer MF Brin JJ Murray JD Wallace A Willmer-Hulme M Koller 1999 Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia Neurology 53 1439 1446
5. A Brashear K Bergan J Wojcieszek ER Siemers W Ambrosius 2000 Patient's perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A Mov Disord 15 150 153
6. MF Brin MF Lew CH Adler CL Comella SA Factor J Jankovic C O'Brien JJ Murray JD Wallace A Willmer-Hulme M Koller 1999 Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia Neurology 53 1431 1438
7. L Camfield Y Ben-Shlomo TT Warner 2002 Impact of cervical dystonia on quality of life Mov Disord 17 838 841
8. J Chan MF Brin S Fahn 1991 Idiopathic cervical dystonia: clinical characteristics Mov Disord 6 119 126
9. CL Comella J Jankovic KM Shannon J Tsui M Swenson S Leurgans W Fan 2005 Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia Neurology 65 1423 1429
10. SR Filipovic M Jahanshahi R Viswanathan P Heywood D Rogers KP Bhatia 2004 Clinical features of the geste antagoniste in cervical dystonia Adv Neurol 94 191 201
11. DJ Gelb DH Lowenstein MJ Aminoff 1989 Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis Neurology 39 80 84
12. N Giladi J Meer H Kidan S Honigman 2000 Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxin Eur Neurol 44 144 146
13. P Greene U Kang S Fahn M Brin C Moskowitz E Flaster 1990 Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis Neurology 40 1213 1218
14. JM Hagenah A Vieregge P Vieregge 2001 Radiculopathy and myelopathy in patients with primary cervical dystonia Eur Neurol 45 236 240
15. J Jankovic S Leder D Warner K Schwartz 1991 Cervical dystonia: clinical findings and associated movement disorders Neurology 41 1088 1091
16. J Jankovic KD Vuong J Ahsan 2003 Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia Neurology 60 1186 1188
17. KR Kessler M Skutta R Benecke 1999 Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group J Neurol 246 265 274
18. MF Lew BT Adornato DD Duane DD Dykstra SA Factor JM Massey MF Brin J Jankovic RL Rodnitzky C Singer MR Swenson D Tarsy JJ Murray M Koller JD Wallace 1997 Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia Neurology 49 701 707
19. IT Lorentz SS Subramaniam C Yiannikas 1991 Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients Mov Disord 6 145 150
20. A Marchetti R Magar L Findley JP Larsen Z Pirtosek E Ruzicka R Jech J Slawek F Ahmed 2005 Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study Mov Disord 20 937 944
21. T Odergren H Hjaltason S Kaakkola G Solders J Hanko C Fehling RJ Marttila H Lundh S Gedin I Westergren A Richardson C Dott H Cohen 1998 A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia J Neurol Neurosurg Psychiatry 64 6 12
22. W Poewe L Schelosky B Kleedorfer F Heinen M Wagner G Deuschl 1992 Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients J Neurol 239 21 25
23. W Poewe G Deuschl A Nebe E Feifel J Wissel R Benecke KR Kessler AO Ceballos-Baumann A Ohly W Oertel G Kunig 1998 What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group J Neurol Neurosurg Psychiatry 64 13 17
24. D Ranoux C Gury J Fondarai JL Mas M Zuber 2002 Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia J Neurol Neurosurg Psychiatry 72 459 462
25. C Sampaio J Costa JJ Ferreira 2004 Clinical comparability of marketed formulations of botulinum toxin Mov Disord 19 Suppl 8 S129 S136
26. CM Shaari I Sanders 1993 Quantifying how location and dose of botulinum toxin injections affect muscle paralysis Muscle Nerve 16 964 969
27. CM Shaari BL Wu HF Biller SK Chuang I Sanders 1998 Botulinum toxin decreases salivation from canine submandibular glands Otolaryngol Head Neck Surg 118 452 457
28. D Truong DD Duane J Jankovic C Singer LC Seeberger CL Comella MF Lew RL Rodnitzky FO Danisi JP Sutton PD Charles RA Hauser GL Sheean 2005 Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study Mov Disord 20 783 791
29. JK Tsui A Eisen E Mak J Carruthers A Scott DB Calne 1985 A pilot study on the use of botulinum toxin in spasmodic torticollis Can J Neurol Sci 12 314 316
30. JK Tsui A Eisen AJ Stoessl S Calne DB Calne 1986 Double-blind study of botulinum toxin in spasmodic torticollis Lancet 2 245 247